Literature DB >> 2663485

Therapy of the malignant carcinoid syndrome.

L K Kvols1.   

Abstract

Although usually associated with carcinoid tumors of the small intestine that have metastasized to the liver, the carcinoid syndrome is seen less frequently with primary tumors arising from other organs such as the lung, pancreas, thymus, stomach, and ovary. The clinical features, pathophysiology and diagnosis, and therapeutic considerations of this syndrome are presented. The management of carcinoid crisis and the results of recent chemotherapy trials are also discussed.

Entities:  

Mesh:

Year:  1989        PMID: 2663485

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  7 in total

Review 1.  Somatostatin analog therapy in treatment of gastrointestinal disorders and tumors.

Authors:  Wouter W de Herder; Steven W J Lamberts
Journal:  Endocrine       Date:  2003-04       Impact factor: 3.633

2.  Observations on relationship between hypergastrinemia, multiple gastric carcinoids, and pancreatic mass.

Authors:  I M Modlin; C J Gilligan; G P Lawton; L H Tang; A B West; R Lindenberg
Journal:  Dig Dis Sci       Date:  1996-01       Impact factor: 3.199

3.  Treatment of the carcinoid syndrome with the longacting somatostatin analogue lanreotide: a prospective study in 39 patients.

Authors:  P Ruszniewski; M Ducreux; J A Chayvialle; J Blumberg; D Cloarec; H Michel; J M Raymond; J L Dupas; H Gouerou; R Jian; E Genestin; P Bernades; P Rougier
Journal:  Gut       Date:  1996-08       Impact factor: 23.059

Review 4.  Carcinoid tumors.

Authors:  Scott N Pinchot; Kyle Holen; Rebecca S Sippel; Herbert Chen
Journal:  Oncologist       Date:  2008-12-17

Review 5.  [Drug therapy of endocrine neoplasms. Part II: Malignant gastrinomas, insulinomas, glucagonomas, carcinoids and other tumors].

Authors:  M Schott; W A Scherbaum; J Feldkamp
Journal:  Med Klin (Munich)       Date:  2000-02-15

6.  Clinical and organizational factors in the initial evaluation of patients with lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Authors:  David E Ost; Sai-Ching Jim Yeung; Lynn T Tanoue; Michael K Gould
Journal:  Chest       Date:  2013-05       Impact factor: 9.410

7.  Primary neuroendocrine carcinoma of the thymus.

Authors:  Gajanan S Gaude; Virupakshi Hattiholi; Prakash R Malur; Jyothi Hattiholi
Journal:  Niger Med J       Date:  2013-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.